423 related articles for article (PubMed ID: 32546242)
1. Failure of anti Interleukin-1 β monoclonal antibody in the treatment of recurrent pericarditis in two children.
Signa S; D'Alessandro M; Consolini R; Miniaci A; Bustaffa M; Longo C; Tosca MA; Bizzi M; Caorsi R; Mendonça LO; Pession A; Ravelli A; Gattorno M
Pediatr Rheumatol Online J; 2020 Jun; 18(1):51. PubMed ID: 32546242
[TBL] [Abstract][Full Text] [Related]
2. Long-term efficacy of interleukin-1 receptor antagonist (anakinra) in corticosteroid-dependent and colchicine-resistant recurrent pericarditis.
Finetti M; Insalaco A; Cantarini L; Meini A; Breda L; Alessio M; D'Alessandro M; Picco P; Martini A; Gattorno M
J Pediatr; 2014 Jun; 164(6):1425-31.e1. PubMed ID: 24630353
[TBL] [Abstract][Full Text] [Related]
3. Anaphylactic reaction to anakinra in a child with steroid-dependent idiopathic recurrent pericarditis and successful management with canakinumab.
Epçaçan S; Sahin S; Kasapcopur O
Cardiol Young; 2019 Apr; 29(4):549-551. PubMed ID: 30931868
[TBL] [Abstract][Full Text] [Related]
4. PAPA Syndrome: Challenges in Achieving Long-Term Remission.
Smajlović H; Prohić A
Acta Dermatovenerol Croat; 2023 Nov; 31(2):106-109. PubMed ID: 38006373
[TBL] [Abstract][Full Text] [Related]
5. Anakinra effectiveness in refractory polyserositis: An Italian multicenter study.
Lopalco G; Venerito V; Brucato A; Emmi G; Giacomelli R; Cauli A; Piga M; Parronchi P; Nivuori M; Malandrino D; Ruscitti P; Vitiello G; Fabiani C; Cantarini L; Iannone F
Joint Bone Spine; 2022 Mar; 89(2):105299. PubMed ID: 34656754
[TBL] [Abstract][Full Text] [Related]
6. Successful use of anakinra for colchicine-intolerant, corticosteroid-dependent recurrent pericarditis secondary to postcardiac injury syndrome after pacemaker placement.
Saad Shaukat MH; Shabbir MA; Mookherjee S; Peredo-Wende R
BMJ Case Rep; 2019 Apr; 12(4):. PubMed ID: 30948415
[TBL] [Abstract][Full Text] [Related]
7. The autoinflammatory side of recurrent pericarditis: Enlightening the pathogenesis for a more rational treatment.
Lopalco G; Rigante D; Cantarini L; Imazio M; Lopalco A; Emmi G; Venerito V; Fornaro M; Frediani B; Nivuori M; Brucato A; Iannone F
Trends Cardiovasc Med; 2021 Jul; 31(5):265-274. PubMed ID: 32376492
[TBL] [Abstract][Full Text] [Related]
8. Anaphylaxis to anakinra in a pediatric patient with systemic juvenile idiopathic arthritis successfully treated with canakinumab: a case-based review.
Aguiar CL; Pan N; Adams A; Barinstein L; Lehman TJ
Clin Rheumatol; 2015 Oct; 34(10):1821-4. PubMed ID: 25697878
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of idiopathic recurrent pericarditis in children with interleukin-1beta receptor antagonist (anakinra): an unrecognized autoinflammatory disease?
Picco P; Brisca G; Traverso F; Loy A; Gattorno M; Martini A
Arthritis Rheum; 2009 Jan; 60(1):264-8. PubMed ID: 19116906
[TBL] [Abstract][Full Text] [Related]
10. Assessment of effectiveness of anakinra and canakinumab in patients with colchicine-resistant/unresponsive familial Mediterranean fever.
Şahin A; Derin ME; Albayrak F; Karakaş B; Karagöz Y
Adv Rheumatol; 2020 Jan; 60(1):12. PubMed ID: 32000860
[TBL] [Abstract][Full Text] [Related]
11. A case report of a novel compound heterozygous mutation in a Brazilian patient with deficiency of Interleukin-1 receptor antagonist (DIRA).
Mendonça LO; Grossi A; Caroli F; de Oliveira RA; Kalil J; Castro FFM; Pontillo A; Ceccherini I; Barros MAMT; Gattorno M
Pediatr Rheumatol Online J; 2020 Aug; 18(1):67. PubMed ID: 32819369
[TBL] [Abstract][Full Text] [Related]
12. Relapse of colchicine-intolerant, corticosteroid-dependent recurrent idiopathic pericarditis after perigestational discontinuation of anakinra: uncertain safety of anakinra in pregnancy and the need for shared decision-making.
Saad Shaukat MH; Fiegen N; Malik MN; Petrasko M
BMJ Case Rep; 2023 Sep; 16(9):. PubMed ID: 37714558
[TBL] [Abstract][Full Text] [Related]
13. Pediatric Recurrent Pericarditis: Appropriateness of the Standard of Care and Response to IL-1 Blockade.
Caorsi R; Insalaco A; Bovis F; Martini G; Cattalini M; Chinali M; Rimini A; Longo C; Federici S; Celani C; Filocamo G; Consolini R; Maggio MC; Fadanelli G; Licciardi F; Romano M; Teruzzi BL; Taddio A; Miniaci A; La Torre F; De Fanti A; Cavalli G; Bigucci B; Gallizzi R; Chinello M; Imazio M; Brucato A; Cimaz R; De Benedetti F; Gattorno M
J Pediatr; 2023 May; 256():18-26.e8. PubMed ID: 36470465
[TBL] [Abstract][Full Text] [Related]
14. Management of idiopathic recurrent pericarditis in adults and in children: a role for IL-1 receptor antagonism.
Brucato A; Emmi G; Cantarini L; Di Lenarda A; Gattorno M; Lopalco G; Marcolongo R; Imazio M; Martini A; Prisco D
Intern Emerg Med; 2018 Jun; 13(4):475-489. PubMed ID: 29633070
[TBL] [Abstract][Full Text] [Related]
15. Anakinra for corticosteroid-dependent and colchicine-resistant pericarditis: The IRAP (International Registry of Anakinra for Pericarditis) study.
Imazio M; Andreis A; De Ferrari GM; Cremer PC; Mardigyan V; Maestroni S; Luis SA; Lopalco G; Emmi G; Lotan D; Marcolongo R; Lazaros G; De Biasio M; Cantarini L; Dagna L; Cercek AC; Pivetta E; Varma B; Berkson L; Tombetti E; Iannone F; Prisco D; Caforio ALP; Vassilopoulos D; Tousoulis D; De Luca G; Giustetto C; Rinaldi M; Oh JK; Klein AL; Brucato A; Adler Y
Eur J Prev Cardiol; 2020 Jun; 27(9):956-964. PubMed ID: 31610707
[TBL] [Abstract][Full Text] [Related]
16. Acute Effects of Interleukin-1 Blockade Using Anakinra in Patients With Acute Pericarditis.
Wohlford GF; Buckley LF; Vecchié A; Kadariya D; Markley R; Trankle CR; Chiabrando JG; de Chazal HM; Van Tassell B; Abbate A
J Cardiovasc Pharmacol; 2020 Jul; 76(1):50-52. PubMed ID: 32398478
[TBL] [Abstract][Full Text] [Related]
17. Effect of interleukin-1 inhibition in a cohort of patients with colchicine-resistant familial Mediterranean fever treated consecutively with anakinra and canakinumab.
Druyan A; Giat E; Livneh A; Grossman C; Ben-Zvi I; Lidar M
Clin Exp Rheumatol; 2021; 39 Suppl 132(5):75-79. PubMed ID: 34369359
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness and Safety of Anakinra for Management of Refractory Pericarditis.
Jain S; Thongprayoon C; Espinosa RE; Hayes SN; Klarich KW; Cooper LT; Moder KG; Anavekar NS; Oh JK; Matteson EL
Am J Cardiol; 2015 Oct; 116(8):1277-9. PubMed ID: 26279106
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of colchicine in addition to anakinra in patients with recurrent pericarditis.
Collini V; Andreis A; De Biasio M; De Martino M; Isola M; Croatto N; Lepre V; Cantarini L; Merlo M; Sinagra G; Abbate A; Lazaros G; Brucato A; Klein AL; Imazio M
Open Heart; 2024 Mar; 11(1):. PubMed ID: 38490715
[TBL] [Abstract][Full Text] [Related]
20. Anakinra in idiopathic recurrent pericarditis refractory to immunosuppressive therapy; a preliminary experience in seven patients.
Dagan A; Langevitz P; Shoenfeld Y; Shovman O
Autoimmun Rev; 2019 Jun; 18(6):627-631. PubMed ID: 30959216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
